Affiliation:
1. Division of Hematology and Oncology, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri
2. Trudy Busch Valentine School of Nursing, Saint Louis University, St. Louis, Missouri
Abstract
There are multiple laboratories that offer germline genetic testing, and it can be difficult to discern which one to use for testing. Some laboratories have more comprehensive analysis techniques and capability, which increases the accuracy of testing. The ordering provider has a responsibility to select the appropriate laboratory with technologic capability for the needed testing, inform the laboratory of prior testing results in the patient and family so known familial variants have targeted testing, and use appropriate terminology and nomenclature when communicating information to other healthcare professionals, patients, and families. This report presents a case illustrating the potential errors that can occur when a provider selects a laboratory that lacks the capacity to detect certain pathogenic variants, such as large deletions and duplications. False-negative germline testing results lead to missed opportunities in prevention and early detection for not only the patient but often multiple family members, which may lead to psychosocial distress and late-detected cancers. This case highlights the complexities of genetic care and why management by a genetics professional can facilitate more fiscally responsible care, appropriate genetic testing, and comprehensive care for all family members at risk.
Reference24 articles.
1. ClinVar [VCV001071269.1]
2. Utility of RNA sequencing analysis in the context of genetic testing;Tahiliani J,2020
3. Lynch syndrome;Idos G
4. Laboratory business models and practices: implications for availability and access to germline genetic testing;Scheuner MT,2021
5. Genetic testing: fraud, waste & abuse: white paper
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献